Exhale-Dx™: A non-invasive, real-time breath analysis system using deep learning for asthma diagnosis.

Journal of biological methods Pub Date : 2025-07-11 eCollection Date: 2025-01-01 DOI:10.14440/jbm.2024.0142
Hanya Ahmed, Jona Angelica Flavier, Victor Higgs
{"title":"Exhale-Dx™: A non-invasive, real-time breath analysis system using deep learning for asthma diagnosis.","authors":"Hanya Ahmed, Jona Angelica Flavier, Victor Higgs","doi":"10.14440/jbm.2024.0142","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Asthma presents significant diagnostic and therapeutic challenges, impacting millions and posing a substantial burden on healthcare systems, particularly in the United Kingdom, where it afflicts roughly 5.4 million individuals. Severe asthma, incurring over 50% of total expenditures, tends to lead to frequent exacerbations and preventable emergency admissions. Traditional diagnostic methods, primarily based on clinical history, can result in delays and misdiagnoses, culpable for over 1,200 deaths annually, 90% of which are considered preventable with timely intervention.</p><p><strong>Objective: </strong>To address this issue, we developed Exhale-Dx™, a point-of-care breath test platform that provides a non-invasive, user-friendly solution for asthma diagnosis and monitoring. Exhale-Dx™ captures volatile organic compounds (VOCs) in exhaled breath, reflecting real-time metabolic and inflammatory markers of lung function. By analyzing these personalized breath signatures, clinicians and patients can detect exacerbations up to three days in advance, thus facilitating early and targeted interventions to reduce emergency care utilization. The system integrates capnographic waveforms, asthma control scores, and clinical lung function data, offering a comprehensive diagnostic profile.</p><p><strong>Methods: </strong>Using Exhale-Dx™ data, we developed the Asthma Diagnostic Enhanced Neural Architecture (ADENA), an advanced deep neural network that leverages VOC biomarkers and lung function data to enhance diagnostic precision.</p><p><strong>Results: </strong>ADENA achieved exceptional performance, delivering 98.7% accuracy, an F1 score of 0.98, and a low mean squared error of 0.065. The deconvolution analysis further confirmed the model's ability to detect significant physiological differences between asthmatic and non-asthmatic profiles.</p><p><strong>Conclusion: </strong>Our findings showed that VOC analysis combined with advanced neural networks could accurately distinguish asthmatic profiles, highlighting their potential for early, non-invasive interventions in respiratory health diagnostics.</p>","PeriodicalId":73618,"journal":{"name":"Journal of biological methods","volume":"12 3","pages":"e99010063"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12422117/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biological methods","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14440/jbm.2024.0142","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Asthma presents significant diagnostic and therapeutic challenges, impacting millions and posing a substantial burden on healthcare systems, particularly in the United Kingdom, where it afflicts roughly 5.4 million individuals. Severe asthma, incurring over 50% of total expenditures, tends to lead to frequent exacerbations and preventable emergency admissions. Traditional diagnostic methods, primarily based on clinical history, can result in delays and misdiagnoses, culpable for over 1,200 deaths annually, 90% of which are considered preventable with timely intervention.

Objective: To address this issue, we developed Exhale-Dx™, a point-of-care breath test platform that provides a non-invasive, user-friendly solution for asthma diagnosis and monitoring. Exhale-Dx™ captures volatile organic compounds (VOCs) in exhaled breath, reflecting real-time metabolic and inflammatory markers of lung function. By analyzing these personalized breath signatures, clinicians and patients can detect exacerbations up to three days in advance, thus facilitating early and targeted interventions to reduce emergency care utilization. The system integrates capnographic waveforms, asthma control scores, and clinical lung function data, offering a comprehensive diagnostic profile.

Methods: Using Exhale-Dx™ data, we developed the Asthma Diagnostic Enhanced Neural Architecture (ADENA), an advanced deep neural network that leverages VOC biomarkers and lung function data to enhance diagnostic precision.

Results: ADENA achieved exceptional performance, delivering 98.7% accuracy, an F1 score of 0.98, and a low mean squared error of 0.065. The deconvolution analysis further confirmed the model's ability to detect significant physiological differences between asthmatic and non-asthmatic profiles.

Conclusion: Our findings showed that VOC analysis combined with advanced neural networks could accurately distinguish asthmatic profiles, highlighting their potential for early, non-invasive interventions in respiratory health diagnostics.

Abstract Image

Abstract Image

Abstract Image

呼气- dx™:一种使用深度学习进行哮喘诊断的非侵入性实时呼吸分析系统。
背景:哮喘呈现出重大的诊断和治疗挑战,影响了数百万人,并对医疗保健系统构成了沉重的负担,特别是在英国,它折磨着大约540万人。严重哮喘占总支出的50%以上,往往导致病情频繁恶化和可预防的急诊入院。主要基于临床病史的传统诊断方法可能导致延误和误诊,每年造成1,200多人死亡,其中90%被认为可以通过及时干预来预防。为了解决这一问题,我们开发了呼气- dx™,这是一种即时呼吸测试平台,为哮喘诊断和监测提供了一种非侵入性、用户友好的解决方案。Exhale-Dx™捕捉呼出气体中的挥发性有机化合物(VOCs),反映肺功能的实时代谢和炎症标志物。通过分析这些个性化的呼吸特征,临床医生和患者可以提前三天发现病情恶化,从而促进早期和有针对性的干预措施,以减少急诊护理的利用。该系统集成了二氧化碳波形、哮喘控制评分和临床肺功能数据,提供了一个全面的诊断概况。方法:利用呼气- dx™数据,我们开发了哮喘诊断增强神经架构(ADENA),这是一种先进的深度神经网络,利用VOC生物标志物和肺功能数据来提高诊断精度。结果:ADENA取得了优异的成绩,准确率为98.7%,F1评分为0.98,均方误差为0.065。反褶积分析进一步证实了该模型检测哮喘和非哮喘谱之间显著生理差异的能力。结论:我们的研究结果表明,VOC分析与先进的神经网络相结合可以准确区分哮喘特征,突出了它们在呼吸健康诊断中的早期、非侵入性干预的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信